Predict your next investment

See what CB Insights has to offer

Investments

3

Portfolio Exits

1

About ATS Beteiligungsverwaltung

About ATS ATS Beteiligungsverwaltung GmbH operates as a "Family Office" for the Strüngmann brothers, offering their know-how and strategic support to selected biotech companies.

ATS Beteiligungsverwaltung Headquarters Location

Germany

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Latest ATS Beteiligungsverwaltung News

Deal in focus: MIG backs Ganymed in €45m series-E

Nov 29, 2013

Save this article   Send to   MIG Verwaltungs has reinvested in biopharmaceutical company Ganymed Pharmaceuticals in a joint €45m series-E financing round, alongside family office ATS Beteiligungsverwaltung, in what marks the largest biotechnology early-stage investment in the DACH region so far this year. In the GP's latest commitment to the Mainz-based company, MIG invested via its MIG Fond 6, 12 and 13 vehicles, which bought 14,575 newly created shares for around €2m, equating to a 1.08% stake in the... To continue reading...

ATS Beteiligungsverwaltung Investments

3 Investments

ATS Beteiligungsverwaltung has made 3 investments. Their latest investment was in GANYMED Pharmaceuticals as part of their Series E on November 11, 2013.

CBI Logo

ATS Beteiligungsverwaltung Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

11/18/2013

Series E

GANYMED Pharmaceuticals

$60.78M

No

2

11/17/2008

Series D

Subscribe to see more

$99M

Subscribe to see more

10

9/18/2007

Series C - II

Subscribe to see more

$99M

Subscribe to see more

10

Date

11/18/2013

11/17/2008

9/18/2007

Round

Series E

Series D

Series C - II

Company

GANYMED Pharmaceuticals

Subscribe to see more

Subscribe to see more

Amount

$60.78M

$99M

$99M

New?

No

Subscribe to see more

Subscribe to see more

Co-Investors

Sources

2

10

10

ATS Beteiligungsverwaltung Portfolio Exits

1 Portfolio Exit

ATS Beteiligungsverwaltung has 1 portfolio exit. Their latest portfolio exit was GANYMED Pharmaceuticals on October 28, 2016.

Date

Exit

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Acquirer

Sources

10/28/2016

Acquired

$99M

10

Date

10/28/2016

Exit

Acquired

Companies

Valuation

$99M

Acquirer

Sources

10

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.